LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/Luna XD and Orbit Systems Relaunch
Spine

Luna XD and Orbit Systems Relaunch

March 26, 2021 2 min read Premium comments

Advertisement

Secondary#spinalelements#lunaxd#orbitsystems

Spinal Elements, Inc. has officially relaunched and engaged in the first clinical use of its Luna® XD multi-expandable lumbar interbody fusion device and the Orbit® articulating discectomy system.

Richard G. Fessler, M.D., Ph.D. of Rush University Medical Group in Chicago was the surgeon performing this procedure, a minimally invasive transforaminal lumbar interbody fusion (TLIF). Spinal Elements acquired the Luna XD and Orbit in December 2020.

“I am very pleased to be using both Orbit and Luna XD in my MIS [minimally invasive surgery] TLIF procedures again,” stated Dr. Fessler. “Orbit is a best-in-class system that allows me to provide a safe and more thorough discectomy while Luna XD’s multi-expandable profile and footprint provides a large area for bone grafting and controlled restoration of disc height and lordosis, contributing to the consistency and positive clinical outcomes of my TLIF procedures. I look forward to sharing these results in an upcoming peer-reviewed publication.”

System Details

The Orbit system features articulating and rotating discectomy instrumentation that uses a minimal, posterior incision and/or MIS tubular approach to, according to the company, “achieve efficient disruption and removal of disc tissue while preparing the endplates for fusion. The novel articulating rotary design allows the instrumentation’s working end to evacuate the full area of the disc necessary for implantation of the Luna XD circular device.”

“The Luna XD allows an ALIF-sized [anterior lumbar interbody fusion], circular implant to be surgically delivered to the intervertebral space through a posterior, minimally-invasive access point. Once inserted, the Luna XD implant first expands horizontally to cover the disc footprint, creating a stable foundation. Then the implant expands vertically up to 16mm to restore disc height. Furthermore, the device includes up to 12° of lordosis to aid in the restoration of sagittal alignment.”

Driving Fusion

Jason Blain, CEO of Spinal Elements, told OTW, “Luna XD and Orbit are each individually unique technologies. The Orbit discectomy system allows the surgeon to reach the contralateral corner of the disc space from the natural approach angle of a TLIF procedure. It is difficult, if not impossible, to reach that area for discectomy with conventional straight instrumentation. Luna XD allows for the placement of an ALIF-sized interbody device from a posterior TLIF approach. The load distribution of a bigger interbody device helps with anterior column support and the size of the aperture within Luna XD provides significant volume for graft material. Fusion is a biologic process requiring proper discectomy and ample biologic material (bone graft) to insure long-term success. Orbit and Luna XD each help meet the goals necessary for successful fusion.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy